LOS ANGELES (Reuters) The U.S Centers for Medicare and Medicaid Services (CMS) said on Wednesday it is reviewing its coverage of anemia drugs used to treat patients with kidney disease.The drugs, Epogen and Aranesp made by Amgen Inc and Proci... red blood cells
To comment or read full article login. No account? Register free.